Rejection

Biogen Inc. Global Phase 3 Overlap Study Evaluates the Efficacy and Safety of Ferzaltamab compared to placebo in adults with delayed AMR AMR is the main cause of kidney transplant …

Pseudomonas-induced antibody-mediated rejection of lung allografts of mice. credit: Science Translation Medicine (2025). doi:10.1126/scitranslmed.adu6563 A large team of surgeons and organ transplant researchers from multiple institutions across the United States …

SAN DIEGO — Kidney transplant patients who move into the newly recognized microvascular inflammation category under the revised definition have a moderate risk of poor allograft outcomes, a large study …

Researchers recently uncovered important insights into a newly defined rejection entity in kidney transplantation, which may improve risk stratification of patients after transplantation. The research will be presented at ASN …

In mice, an approach that blocks inflammation extends organ survival from about a week to more than two months A new study by scientists at Cincinnati Children's Hospital shows there …

Currently we must have an exact match to receive an organ from a donor, especially kidneys, but that may no longer be an issue.

PHILADELPHIA (CBS) — A young woman from Montgomery County is fighting desperately for her life: She needs a lung transplant but most hospitals are turning her down. Following tubing to …

82% (n=9/11) of patients who received felzaltamab experienced resolution of symptoms. Antibody-mediated rejection The proportion of patients meeting the Banff criteria in the 24-week biopsy was significantly increased compared to …

Ankit Bharat, MBBS, the Harold L. and Margaret N. Methods Professor of Surgery and chief of the Department of Thoracic Surgery, is co-author of the study published in the Journal …

TFF Pharma Co., Ltd. Oral Presentation Presenting Latest Data from a Phase 2 Study Demonstrating Successful Transition of Patients from Oral Tacrolimus to TFF TAC FORT WORTH, Texas, March 25, …